Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Makrides

Showing results (221-230 of 238) with videos related to

Pageof 24
Sort By:
The New England Journal of Medicine|September 12, 2019
A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm DeliveryMaria Makrides, Karen Best, Lisa Yelland, et al.
BMJ Open|February 7, 2021
Protocol for assessing whether cognition of preterm infants <29 weeks' gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trialJacqueline F Gould, Maria Makrides, Thomas R Sullivan, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|July 28, 2018
Effects of diets enriched in linoleic acid and its peroxidation products on brain fatty acids, oxylipins, and aldehydes in miceChristopher E Ramsden, Marie Hennebelle, Susanne Schuster, et al.
The American Journal of Clinical Nutrition|May 10, 2019
Docosahexaenoic acid supplementation of preterm infants and parent-reported symptoms of allergic disease at 7 years corrected age: follow-up of a randomized controlled trialAnoja W Gunaratne, Maria Makrides, Carmel T Collins, et al.
BMJ Open|February 8, 2020
Effect of once weekly folic acid supplementation on erythrocyte folate concentrations in women to determine potential to prevent neural tube defects: a randomised controlled dose-finding trial in MalaysiaKaitlyn L I Samson, Su Peng Loh, Geok Lin Khor, et al.
BMJ Global Health|December 4, 2020
Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in MalaysiaKaitlyn L I Samson, Su Peng Loh, Siew Siew Lee, et al.
BMJ Open|March 20, 2015
Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trialCarmel T Collins, Robert A Gibson, Peter J Anderson, et al.
The New England Journal of Medicine|October 27, 2022
Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 YearsJacqueline F Gould, Maria Makrides, Robert A Gibson, et al.
JAMA Network Open|June 9, 2023
Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born PretermThomas R Sullivan, Jacqueline F Gould, Jana M Bednarz, et al.
BMJ Open|May 10, 2023
Prenatal iodine supplementation and early childhood neurodevelopment: the PoppiE trial - study protocol for a multicentre randomised controlled trialKaren P Best, Jacqueline F Gould, Maria Makrides, et al.
Pageof 24

Showing results (221-230 of 238) with videos related to

Sort By:
Pageof 24
The New England Journal of Medicine|September 12, 2019
A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm DeliveryMaria Makrides, Karen Best, Lisa Yelland, et al.
BMJ Open|February 7, 2021
Protocol for assessing whether cognition of preterm infants <29 weeks' gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trialJacqueline F Gould, Maria Makrides, Thomas R Sullivan, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|July 28, 2018
Effects of diets enriched in linoleic acid and its peroxidation products on brain fatty acids, oxylipins, and aldehydes in miceChristopher E Ramsden, Marie Hennebelle, Susanne Schuster, et al.
The American Journal of Clinical Nutrition|May 10, 2019
Docosahexaenoic acid supplementation of preterm infants and parent-reported symptoms of allergic disease at 7 years corrected age: follow-up of a randomized controlled trialAnoja W Gunaratne, Maria Makrides, Carmel T Collins, et al.
BMJ Open|February 8, 2020
Effect of once weekly folic acid supplementation on erythrocyte folate concentrations in women to determine potential to prevent neural tube defects: a randomised controlled dose-finding trial in MalaysiaKaitlyn L I Samson, Su Peng Loh, Geok Lin Khor, et al.
BMJ Global Health|December 4, 2020
Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in MalaysiaKaitlyn L I Samson, Su Peng Loh, Siew Siew Lee, et al.
BMJ Open|March 20, 2015
Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trialCarmel T Collins, Robert A Gibson, Peter J Anderson, et al.
The New England Journal of Medicine|October 27, 2022
Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 YearsJacqueline F Gould, Maria Makrides, Robert A Gibson, et al.
JAMA Network Open|June 9, 2023
Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born PretermThomas R Sullivan, Jacqueline F Gould, Jana M Bednarz, et al.
BMJ Open|May 10, 2023
Prenatal iodine supplementation and early childhood neurodevelopment: the PoppiE trial - study protocol for a multicentre randomised controlled trialKaren P Best, Jacqueline F Gould, Maria Makrides, et al.
Pageof 24